HSBC Downgrades AstraZeneca to Hold Rating, Cuts PT

08:30 AM EDT, 07/13/2026 (MT Newswires) -- HSBC on Monday downgraded pharmaceutical giant AstraZeneca (AZN.L, AZN.ST) to hold from buy and lowered its price target to 137.50 pounds sterling from 165 pounds. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)